Clinical trial
A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
NCT04629950 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 19, 2021
- Completion date
- November 18, 2024
- Enrollment
- 41 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.